ATE234109T1 - Cetp zur erhöhung des hdl-cholesterol-gehalts - Google Patents

Cetp zur erhöhung des hdl-cholesterol-gehalts

Info

Publication number
ATE234109T1
ATE234109T1 AT96918201T AT96918201T ATE234109T1 AT E234109 T1 ATE234109 T1 AT E234109T1 AT 96918201 T AT96918201 T AT 96918201T AT 96918201 T AT96918201 T AT 96918201T AT E234109 T1 ATE234109 T1 AT E234109T1
Authority
AT
Austria
Prior art keywords
cetp
hdl cholesterol
cholesterol content
increase hdl
stimulating
Prior art date
Application number
AT96918201T
Other languages
English (en)
Inventor
Deborah Y Kwoh
Steven W Brostoff
Dennis J Carlo
Original Assignee
Avant Immunotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avant Immunotherapeutics Inc filed Critical Avant Immunotherapeutics Inc
Application granted granted Critical
Publication of ATE234109T1 publication Critical patent/ATE234109T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Ink Jet Recording Methods And Recording Media Thereof (AREA)
  • Color Television Image Signal Generators (AREA)
  • Materials For Photolithography (AREA)
AT96918201T 1995-06-06 1996-06-05 Cetp zur erhöhung des hdl-cholesterol-gehalts ATE234109T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48245495A 1995-06-06 1995-06-06
PCT/US1996/009143 WO1996039168A1 (en) 1995-06-06 1996-06-05 Method for increasing hdl cholesterol level

Publications (1)

Publication Number Publication Date
ATE234109T1 true ATE234109T1 (de) 2003-03-15

Family

ID=23916145

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96918201T ATE234109T1 (de) 1995-06-06 1996-06-05 Cetp zur erhöhung des hdl-cholesterol-gehalts

Country Status (9)

Country Link
US (1) US7074407B1 (de)
EP (1) EP0831881B1 (de)
JP (1) JP3910635B2 (de)
AT (1) ATE234109T1 (de)
CA (1) CA2223177A1 (de)
DE (1) DE69626642T2 (de)
DK (1) DK0831881T3 (de)
ES (1) ES2190470T3 (de)
WO (1) WO1996039168A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410022B1 (en) 1995-05-01 2002-06-25 Avant Immunotherapeutics, Inc. Modulation of cholesteryl ester transfer protein (CETP) activity
JP3910635B2 (ja) 1995-06-06 2007-04-25 アバント イミュノーセラピューティクス，インコーポレイテッド Ｈｄｌコレステロールレベルを増大する方法
US6284533B1 (en) 1996-05-01 2001-09-04 Avant Immunotherapeutics, Inc. Plasmid-based vaccine for treating atherosclerosis
US6846808B1 (en) 1996-05-01 2005-01-25 Avant Immunotherapeutics, Inc. Plasmid-based vaccine for treating atherosclerosis
JP2001520204A (ja) * 1997-10-20 2001-10-30 アヴァント イムノセラピューティクス，インコーポレーテッド コレステリルエステル運搬タンパク質（ｃｅｔｐ）活性を調節するための異種ｃｅｔｐ
US6300308B1 (en) * 1997-12-31 2001-10-09 Board Of Regents, The University Of Texas System Methods and compositions for inducing autoimmunity in the treatment of cancers
AU2234801A (en) * 1999-12-13 2002-04-29 Universidad Nacional Autonoma De Mexico Immunoenzymatic quantification method
MX347400B (es) * 2012-06-29 2017-04-18 Univ Nac Autónoma De México Vacuna de aplicacion nasal contra el desarrollo de la enfermedad aterosclerotica y el higado graso.
CN105859837B (zh) 2014-10-22 2020-11-20 台北医学大学 胆固醇酯转运蛋白抗原肽和融合蛋白以及其组合物和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143305A (en) 1973-05-07 2000-11-07 The Ohio State University Antigenically modified polypeptides composition
US5126399A (en) 1986-04-30 1992-06-30 Board Of Regents, The University Of Texas System Methods and compositions for the preparation and use of site-directed immunologic reagents
US5338829A (en) 1988-04-20 1994-08-16 Trustees Of The University Of Pennsylvania Peptides derived from human immunodeficiency virus-1 GP160
GB8812214D0 (en) 1988-05-24 1988-06-29 Hoffmann La Roche Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
US5242687A (en) 1989-03-15 1993-09-07 Tkb Associates Limited Partnership Method of reducing cellular immune response involving T-cells using CD8-bearing antigen presenting cells
US5264341A (en) * 1989-08-30 1993-11-23 Eli Lilly And Company Selective cloning for high monoclonal antibody secreting hybridomas
WO1992010203A1 (en) 1990-12-10 1992-06-25 Alving Carl R A vaccine against cholesterol to prevent hypercholesterolemia and atherosclerosis
EP0618803A4 (de) * 1991-12-19 1995-03-22 Southwest Found Biomed Res Polypeptide als inhibitoren gegen cholesterylester-transferase, antikörper gegen die synthetischen polypeptide und prophylaktische und therapeutische behandlungsweisen der atherosklerose.
WO1993023076A1 (en) 1992-05-20 1993-11-25 The Johns-Hopkins University Alternative receptor therapy
US5279540A (en) 1992-09-24 1994-01-18 Davidson Michael H Method for reducing the risk of atherosclerosis
US5618683A (en) 1993-04-13 1997-04-08 Brocia; Robert W. Diagnostic kit for cholesteryl ester transfer protein (CETP) activity measurement and a new synthetic particle used therein
US5759551A (en) 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
CA2161445C (en) 1993-04-27 2009-06-30 Anna Efim Ladd Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
AU683295B2 (en) * 1993-08-04 1997-11-06 Texas Biomedical Research Institute CETP inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments
DK96493D0 (da) 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
EP0733061A1 (de) 1994-11-12 1996-09-25 LG Chemical Limited Peptidinhibitoren des Cholesterylesther - Transferprotein und prophylaktische und therapeutische anti - artheriosklerose Agenten
US5705388A (en) 1994-12-23 1998-01-06 Ribozyme Pharmaceuticals, Inc. CETP Ribozymes
US6410022B1 (en) 1995-05-01 2002-06-25 Avant Immunotherapeutics, Inc. Modulation of cholesteryl ester transfer protein (CETP) activity
JP3910635B2 (ja) 1995-06-06 2007-04-25 アバント イミュノーセラピューティクス，インコーポレイテッド Ｈｄｌコレステロールレベルを増大する方法
US6284533B1 (en) 1996-05-01 2001-09-04 Avant Immunotherapeutics, Inc. Plasmid-based vaccine for treating atherosclerosis
EP0914427B1 (de) 1996-05-01 2006-03-29 Avant Immunotherapeutics, Inc. Impfstoff auf einem plasmid beruhend zur behandlung von atherosclerosis
US5994310A (en) 1998-09-03 1999-11-30 Bayer Corporation Peptide ligands for affinity purification of human Factor VIII

Also Published As

Publication number Publication date
CA2223177A1 (en) 1996-12-12
WO1996039168A1 (en) 1996-12-12
JP3910635B2 (ja) 2007-04-25
US7074407B1 (en) 2006-07-11
DE69626642D1 (de) 2003-04-17
DK0831881T3 (da) 2003-07-07
AU6091296A (en) 1996-12-24
EP0831881A1 (de) 1998-04-01
JPH11507910A (ja) 1999-07-13
ES2190470T3 (es) 2003-08-01
AU715410B2 (en) 2000-02-03
EP0831881B1 (de) 2003-03-12
DE69626642T2 (de) 2004-01-29

Similar Documents

Publication Publication Date Title
NZ314058A (en) Use of ganglioside-KLH conjugate vaccines with QS-21 to treat cancer
IL111134A0 (en) Immunological tolerance-inducing agent
TR199801722T2 (xx) Peptit imm�nojenler.
AU2002302255A1 (en) Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
MXPA02005576A (es) Vacuna para la prevencion y tratamiento de la enfermedad de alzheimer y otras enfermedades relacionadas con amiloides.
IL141868A0 (en) Novel methods for therapeutic vaccination
HU9500571D0 (en) Retro-, inverso-, and retro-inverso synthetic peptide analogues
ATE373016T1 (de) Induktion von immunologischer toleranz gegen einen therapeutischen antikörper durch varianten des therapeutischen antikörpers
OA09802A (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus.
EP0090581A3 (de) Kleine, für Maul- und Klauenseuche spezifische Peptide
DE69626642D1 (de) Cetp zur erhöhung des hdl-cholesterol-gehalts
DE69333448D1 (en) P53 impfstoff
NZ312502A (en) Clostridium difficile toxins as mucosal adjuvants
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
BR0312808A (pt) Proteìna de fusão igg fc/hiv-gp120/c3d
WO2003000719A3 (en) Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same
GB9406492D0 (en) Malaria peptides
ZA915230B (en) Ehv-4 glycoprotein vaccine
WO2000069915A3 (en) COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES
HU9301797D0 (en) Utilization of il-4 for producing pharmaceutical preparatives improving immunoreaction
GR3024670T3 (en) Induction of protection against viral infection
GB9818133D0 (en) Vaccine
WO2002004497A3 (en) Multiple antigenic peptides immunogenic against streptococcus pneumoniae
DE69233271D1 (de) Therapeutischer- und präventivimpfstoff gegen hiv
WO2000018429A3 (en) Vaccine based on attenuated $i(haemophilus somnus)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0831881

Country of ref document: EP

REN Ceased due to non-payment of the annual fee